Yujan Shrestha, MD

This interactive session will explore the rapidly evolving landscape of FDA regulations, focusing on thorny issues such as continuous learning systems, the integration of large language models (LLMs), and the debate between lab-developed tests and commercial vendor solutions. Participants will engage in point-counter-point discussion, utilize a whiteboard for collaborative brainstorming, and contrast current regulatory approaches…